Navigation Links
Legionella pneumophila DFA

ProductsLegionella pneumophila DFA
Company ARUP Laboratories
Item Legionella pneumophila DFA
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. MonoFluo Legionella pneumophilia IFA Test
2. Legionella IgG/M II ELISA
3. Legionella Urinary Antigen ELISA
4. Probe Tec ET Legionella pneumophila DNA Amplified Assay
5. OnarLp-QP: Legionella diagnostic for real-time PCR
6. Legionella pneumophila IgG/IgM
7. OnarLp: Legionella diagnostic for conventional PCR
8. NOW® Legionella
9. Legionella Latex Test
10. Legionella IgG/M II
11. Legionella Urinary Antigen (Binax)
The Contoured Wrist/Forearm Support provides comfort for post-surgical immobilization, post-fracture casting, and wrist sprains and strains.
ManuTrain is an active wrist support that has optional features for increased stabilization.
...he Hand and Wrist Cryo/Cuff combines the therapeut...hemarthrosis and swelling, and cold to minimize pa...be repositioned for desired hand coverage. ,For a... cuff and can be removed if a wider range of motio...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products:
(Date:7/25/2008)...ter financial results -, LAVAL, QC, July 25 /PRNe...AQ: DDSS) today announced that it will host a conf...to discuss its second quarter 2008,financial resul...financial,results via news release at approximatel...ce call by telephone, dial 416-646-3095 or,1-800-8...
(Date:7/25/2008)...oviral therapy may be due to genetic factors , ... study challenges the long-held belief that the he...ability to restore itself after HIV patients are t...HAART). , From 50 percent to 90 percent of HIV-...travenous drug use is the main cause of both types...
(Date:7/25/2008)...American Society for Gastrointestinal Endoscopy (A...y in the bariatric surgery patient. The rising pre...ccess in surgical interventions led to a marked in...ormed in the U.S., from 13,365 in 1998 to 102,794 ...reoperative patient and the postoperative patient,...
(Date:7/25/2008)...mber of jobs created in the medical field slowed i...ent kind of slowdown: they laid off fewer people i... Seattle, WA (PRWEB) July 25, 2008 -- Thou... slowed in June overall, pharmaceutical companies ... music to the ears of sales representatives: fewer...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3
...ant constituents of foods in the cereal category a...s an integral part of health-conscious consumers. ...t more of the soluble oat fiber called beta-glucan...has been developed by Agricultural Research Servic...
...skin cancer is the most common tumor to be diagnos...researchers from University Hospital of Navarra. /...g steadily over the recent years. It is the number.... In the U.S., the number of new cases has risen f...
...linic scientists have unearthed a new virus in hum...und in mice, but not in humans. While it is too ea...virus and // prostate cancer is, the study aims to...entists say that this new discovery was made by us...
...loped a biosensor to detect the E. Coli bacteria, .... The biosensor is said to detect the bacteria rap...loped by the University of Rochester Medical Centr...ia as part of the sensing system that includes a s...
Other Medicine News:Health News:New Technique Could Revolutionize Melanoma Diagnosis and Treatment 2
(Date:7/22/2008).../ -- Nonin Medical, a leading innovator,of physiol..., has entered,the clinical testing phase with its ... saturation. Today,s most common application for t... regional blood oxygenation,in the brain -- cerebr...m an ongoing clinical study at the,Duke University...
(Date:7/22/2008)...pment Plan Completed Successfully, DUBLIN, Irelan...ation,plc (NASDAQ: AMRN ) today announced that th...Food and Drug Administration (FDA) to discuss the,...t of,hypertriglyceridemia. Following these discuss...R101 in hypertriglyceridemia., Dr. Declan Doogan,...
(Date:7/22/2008)...ms Tyrima Exhibits Excellent Drug-Like ...port Initiation of Phase II Clinical Trials -, RE...- CeNeRx BioPharma,Inc., a clinical stage company...nts for diseases of the central nervous system, to...Tyrima(TM) into Phase II trials for the,treatment ...
(Date:7/22/2008)...e Importance to Patients of Passing a ...ND, Va., July 22 /- Insmed ...ologics and biopharmaceuticals, today,announced th...ent at a,Congressional briefing on Friday, July 25...lishing an approval pathway for follow-on,biologic...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Penn biochemist receives NIH New Innovators Award 705 1Penn biochemist receives NIH New Innovators Award 705 2Operation Mend Offers New Hope for Wounded Warriors 3031 1Operation Mend Offers New Hope for Wounded Warriors 3031 2Operation Mend Offers New Hope for Wounded Warriors 3031 3UNC faculty and students to develop plan to get clean water in poorer homes 3030 1UNC faculty and students to develop plan to get clean water in poorer homes 3030 2UNC faculty and students to develop plan to get clean water in poorer homes 3030 3Primitive Plants Have Complex Sex Life 3028 1
...007, SAN DIEGO, and SEOUL, South Korea, April 13,/...nc. and LG Life,Sciences, Ltd., presented data fro...retains potency against multiple mutant strains of...mivudine,adefovir, entecavir or telbivudine, duri...g of the European Association for the Study,of the...
... B e-Antigen,(HBeAg)-Negative Patients Achieved Un...PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstC...ed data from a cohort of,nucleoside-naive HBeAg-ne...n=99). These data showed that patients who,experie...blood,after interruption of treatment with BARACLU...
Other Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5